Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06543823

ST250 as a Therapeutic Option for Head & Neck Reconstruction

The Use of Suprathel®250 as a Novel Therapeutical Option for Mucosal Healing in Head and Neck Surgery

Status
Recruiting
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Alaa Emara · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

To assess the use of SupraThel 250 for mucosal reconstruction in the Head \& Neck region. The membrane will be applied after tonsillectomy procedures and compared to bare wounds' healing

Detailed description

After tonsillectomy procedures, the wound is usually left bare to heal. This causes severe pain postoperatively and postoperative hemorrhage. SupraTHEL 250 is a synthetic biodegradable PLA membrane which is proven as a skin membrane in burn wounds with excellent result. We therefore hypothesize that the use opf SupraTHEL 250 after tonsillectomy procedures will allow for faster , less painful healing of the wound bed which allows for a better quality of life for the patients.

Conditions

Interventions

TypeNameDescription
DEVICESupraTHEL 250the membrane is placed onto the wound bed and fixed in place by resorbable interrupted sutures
OTHERComparatorno membrane is placed onto the wound bed , left bare to heal

Timeline

Start date
2025-04-30
Primary completion
2025-12-01
Completion
2026-02-01
First posted
2024-08-09
Last updated
2025-05-18

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT06543823. Inclusion in this directory is not an endorsement.